Holen Sie sich die Stockscreener-App
1.81
0.56%
0.01
Handel nachbörslich:
1.81
Schlusskurs vom Vortag:
$1.80
Offen:
$1.84
24-Stunden-Volumen:
675.74K
Relative Volume:
2.18
Marktkapitalisierung:
$2.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.35M
KGV:
-3.9348
EPS:
-0.46
Netto-Cashflow:
$-5.48M
1W Leistung:
-3.21%
1M Leistung:
+13.12%
6M Leistung:
-54.41%
1J Leistung:
-91.49%
1-Tages-Spanne:
$1.775
$2.39
1-Wochen-Bereich:
$1.62
$2.39
52-Wochen-Spanne:
$1.26
$25.25
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Firmenname
Shuttle Pharmaceuticals Holdings Inc
Sektor
Telefon
(240) 403-4212
Adresse
401 PROFESSIONAL DRIVE, GAITHERSBURG
Vergleichen Sie SHPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
1.81 | 2.89M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
125.90 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.02 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.95 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
496.72 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Shuttle Pharmaceuticals Holdings Inc Aktie (SHPH) Neueste Nachrichten
Shuttle Pharmaceuticals Accelerates Equity Payment in Asset Deal - The Globe and Mail
Shuttle Pharmaceuticals Holdings Signs First Amendment to Asset Purchase Agreement With 1542770 BC - TradingView — Track All Markets
Shuttle Pharmaceuticals Holdings Inc Stock Analysis and ForecastSupport Zone Identification & High Return Stock Ideas - earlytimes.in
What drives Shuttle Pharmaceuticals Holdings Inc stock priceTake Profit Strategies & Free Triple Digit Wealth Increase - earlytimes.in
Astec LifeSciences Limited Stages Intraday Comeback Trend ChangeVolatility Adjusted Trading & Rapid Capital Appreciation - earlytimes.in
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 6.3% – Time to Sell? - Defense World
How Shuttle Pharmaceuticals Holdings Inc. stock benefits from global expansion2025 Market Outlook & Accurate Buy Signal Notifications - Улправда
Will Shuttle Pharmaceuticals Holdings Inc. stock benefit from AI adoptionPortfolio Return Summary & Reliable Price Breakout Signals - Улправда
Can Shuttle Pharmaceuticals Holdings Inc. stock deliver strong Q4 earningsTrade Volume Report & Free Long-Term Investment Growth Plans - Улправда
How Shuttle Pharmaceuticals Holdings Inc. stock reacts to job market dataWall Street Watch & High Yield Equity Trading Tips - Улправда
Aug Spikes: Will Shuttle Pharmaceuticals Holdings Inc. stock benefit from infrastructure spendingEarnings Recap Summary & Reliable Price Breakout Alerts - Улправда
Shuttle Pharmaceuticals Completes Strategic Asset Acquisition - MSN
Patterns Watch: Will Shuttle Pharmaceuticals Holdings Inc. stock benefit from infrastructure spendingPortfolio Gains Summary & AI Based Buy/Sell Signal Reports - Улправда
Is Shuttle Pharmaceuticals Holdings Inc. stock a buy on dipsBuy Signal & Low Drawdown Investment Ideas - ulpravda.ru
A activityGDP Growth & Free Safe Capital Growth Stock Tips - DonanımHaber
How Shuttle Pharmaceuticals Holdings Inc. stock reacts to oil pricesOptions Play & AI Forecasted Stock Moves - Bölüm Sonu Canavarı
Can Shuttle Pharmaceuticals Holdings Inc. stock deliver consistent earnings growth2025 Buyback Activity & Precise Trade Entry Recommendations - Улправда
Trade Report: How Shuttle Pharmaceuticals Holdings Inc. stock benefits from tech adoptionJuly 2025 Review & Verified Trade Idea Suggestions - Улправда
Published on: 2025-12-19 03:09:15 - ulpravda.ru
Shuttle Pharmaceuticals’ Terminated Glioblastoma Trial: What Investors Need to Know Now - TipRanks
Shuttle Pharmaceuticals’ terminated glioblastoma trial: What investors need to know now - MSN
Shuttle Pharmaceuticals Raises $2.5 Million in Private Placement - MSN
Shuttle Pharmaceuticals (NASDAQ: SHPH) details 625,156-share resale registration - Stock Titan
Retail Surge: How Shuttle Pharmaceuticals Holdings Inc. stock benefits from global expansionEarnings Beat & Expert Approved Trade Ideas - moha.gov.vn
Published on: 2025-12-06 06:28:12 - moha.gov.vn
Shuttle Pharmaceuticals Holdings Inc. (SHPH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Shuttle Pharmaceuticals Holdings Inc. stock gain from government policiesEarnings Summary Report & Verified High Yield Trade Plans - Newser
Why Shuttle Pharmaceuticals Holdings Inc. stock is favored by pension fundsJuly 2025 Volume & Free Technical Confirmation Trade Alerts - Newser
Shuttle Pharmaceuticals (SHPH) Stock Analysis Report | Financials & Insights - Benzinga
Shuttle Pharmaceuticals CFO Resigns, Interim CEO Steps In - The Globe and Mail
Shuttle Pharmaceuticals CFO resigns, interim CEO steps in as acting CFO By Investing.com - Investing.com UK
Shuttle Pharmaceuticals CFO resigns, interim CEO steps in as acting CFO - Investing.com
Shuttle Pharmaceuticals Holdings IncTimothy Lorber resigns as CFO of Shuttle PharmaceuticalsSEC filing - marketscreener.com
Shuttle Pharmaceuticals Announces CFO Resignation and Interim Appointment - TradingView
You might want to take a look at Shuttle Pharmaceuticals Holdings Inc (SHPH) now - Setenews
SHPH closes AI platform asset deal with capped stock consideration - Stock Titan
Shuttle Pharmaceuticals Faces Agreement Termination and Settlement - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) -12.6% in Normal Trading: Stock Slides Despite Recent Acquisition - Stocks Telegraph
Shuttle Pharmaceuticals acquires AI firm Molecule.ai for $8 million By Investing.com - Investing.com Australia
Why Does SHPH Stock Dip? - StocksToTrade
Stocks to Watch: Shuttle Pharma, Butterfly Network, Captivision - 富途牛牛
Shuttle Pharmaceuticals settles Theradex dispute and discontinues Ropidoxuridine trials - Investing.com
Shuttle Pharmaceuticals settles Theradex dispute and discontinues Ropidoxuridine trials By Investing.com - Investing.com UK
[8-K] Shuttle Pharmaceuticals Holdings, Inc. Reports Material Event | SHPH SEC FilingForm 8-K - Stock Titan
Shuttle Pharmaceuticals stock falls after closing Molecule.ai acquisition - Investing.com
Shuttle Pharmaceuticals stock falls after closing Molecule.ai acquisition By Investing.com - Investing.com South Africa
Finanzdaten der Shuttle Pharmaceuticals Holdings Inc-Aktie (SHPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.19%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):